Last reviewed · How we verify
NCT03463356
Brief Shame Intervention Study
NA trial testing Shame Intervention in Shame in 14 participants. Completed in 30 June 2018.
30 June 2018
Quick facts
| Lead sponsor | Miami University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 14 |
| Start date | 15 February 2018 |
| Primary completion | 30 June 2018 |
| Estimated completion | 30 June 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Shame Intervention
Conditions studied
- Shame — all drugs for Shame →
- Social Anxiety Disorder — all drugs for Social Anxiety Disorder →
Sponsor
Miami University
Who can join
Adults 18 to 100, any sex, with Shame or Social Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current project will develop and test a brief 2-session shame intervention in individuals diagnosed with social anxiety disorder (SAD). Using a non-concurrent multiple baseline design, the investigators will determine whether the brief shame intervention leads to reductions in trait self-reported shame and state shame in response to an in vivo stressor task. The investigators will also evaluate the effect of changes in shame on trait SAD symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03463356
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Shame
Currently open trials in the same condition.
- NCT07294001 — Shame-Focused Cognitive Behavioral Therapy For Reducing Suicide Risk In Adolescent Psychiatric Inpatients (SF-CBT) · NA · recruiting
Other Miami University trials
Trials by the same sponsor.
- NCT06842225 — Interactive Roles of Cardiorespiratory Fitness and Adiposity on Glucose and Vascular Control After Physical Inactivity · NA · not yet recruiting
- NCT06627777 — From Toddler to Early Adolescent Emotion Regulation Strategies · NA · enrolling by invitation
- NCT05980299 — Testing the Feasibility of the Individualized Positive Psychosocial Intervention (IPPI) · NA · completed
- NCT04103385 — Reconnecting: Improving Interoception to Reduce Suicidal Ideation in the Military · NA · completed
- NCT02968095 — Text Message Support to Prevent Smoking Relapse · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03463356 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Miami University
- Last refreshed: 7 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03463356.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing